21-Deoxycortisol-d8
Based on 1 Customer Validation
21-Deoxycortisol-d8 is the d8-labeled 21-Deoxycortisol (HY-113405). 21-Deoxycortisol is an adrenal-specific C21 steroid that accumulates via alternative pathways due to 21-hydroxylase (CYP21A2/P450c21) deficiency. 21-Deoxycortisol serves as a sensitive and specific biomarker for steroid 21-hydroxylase deficiency (21OHD).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.79%
- CAS No.: 2479914-04-8
- Formule: C21H22D8O4
- Masse moléculaire:354.51
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-P1438
Neuropeptide S(Rat)Endogenous Ligand -
HY-N11224
Pregnanetriol17α-Hydroxyprogesterone Metabolite -
HY-141672
17β-Estradiol sulfate sodium -
HY-N0390S2
L-Glutamine-d5Stable?Isotope -
HY-Y0966S8
Glycine-d5Stable Isotope -
HY-N0437S
Progesterone-d9Stable Isotope -
HY-I1124
L-Valine-d8Stable Isotope -
HY-113251
2-HydroxyestroneAntiestrogenic Agent -
HY-W012352
2-HydroxyanthraquinoneWnt/β-catenin Inhibitor -
HY-76847S
Chenodeoxycholic Acid-d4Stable Isotope -
HY-W009300
4-HydroxyestroneEstrogen Metabolite -
HY-N7264S
7α-Hydroxycholesterol-d7Stable Isotope
Voir tous les produits spécifiques à Isoform Endogenous Metabolite
More
Activité biologique
Description
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 2479914-04-8
-
Unlabeled CAS 641-77-0
-
Appearance Solid
-
Masse moléculaire 354.51
-
Formule C21H22D8O4
-
Color White to off-white
-
SMILES
C[C@@]12[C@](CC[C@]2(O)C(C([2H])([2H])[2H])=O)([H])[C@@]3([H])[C@@]([C@H](C1)O)([H])[C@@]4(C(C([2H])([2H])C3)=C([2H])C(C([2H])([2H])C4)=O)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Pureté et documentation
-
Fiche technique (273 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
[2]. Franks RC. Plasma 17-hydroxyprogesterone, 21-deoxycortisol and cortisol in congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1974;39(6):1099-1102. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
21-Deoxycortisol-d8 Related Classifications
HY-113405S1 Related Classifications
Powered by Bioz
Keywords
- 21-Deoxycortisol-d8
- 2479914-04-8
- Isotope-Labeled Compounds
- Endogenous Metabolite
- steroid 21-hydroxylase deficiency
- nonclassic congenital adrenal hyperplasia
- congenital adrenal hyperplasia
- adrenal steroid
- CYP21A2 heterozygosity
- 11β-hydroxylase
- hyperandrogenic females
- 17-hydroxyprogesterone
- polycystic ovary syndrome
- premature infants
- Inhibitor
- inhibitor
- inhibit